Loading market data...
Friday, August 21, 2026
Back to HomeStock AnalysisPremiumAll CME Group coverage

CME Group (CME) Q2 2026: Trading Fees Slip 2.6%, Market Data Hits Record $238M

By MinJeKim3 views
Share
CME Group (CME) Q2 2026: Trading Fees Slip 2.6%, Market Data Hits Record $238M

CME Group (CME) Q2 2026: Trading Fees Slip 2.6%, Market Data Hits Record $238M

The volatility trade that powered CME Group's first quarter cooled in the second, and the exchange's core fee engine went into reverse. Clearing and transaction fees fell to $1,352.5 million from $1,388.0 million a year earlier, a 2.6% decline, as aggregate average daily volume slipped 1% to 29.8 million contracts and the average fee earned per contract dropped to $0.678 from $0.690 — and that rate decline would have been worse without a clearing and transaction fee increase that took effect on April 1, 2026. The swing from the first quarter is stark: those same fees had risen 15.4% year over year in the first three months of 2026, to $1,542.6 million from $1,337.3 million. Total revenue still edged up 0.8% to $1,706.2 million, because market data and information services jumped 20.2% to a record $238.1 million and other revenue added $9.7 million — together more than covering the $35.5 million fee shortfall. Net income rose 1.6% to $1,041.8 million, but that increase came entirely from below the tax line: pre-tax income actually slipped 0.2% to $1,327.7 million. The quarter is best read as a live test of whether CME's non-transaction revenue can hold the line when trading activity normalizes, and the answer for now is a qualified yes.

All figures are taken from CME Group's Form 10-Q for the quarter ended June 30, 2026 and the company's July 22, 2026 earnings release unless otherwise noted.


1. Consolidated Balance Sheet

1-1. Principal asset items

One structural point comes first. CME's balance sheet is dominated by $158,110.7 million of performance bonds and guaranty fund contributions — collateral that clearing members post to secure their positions. It appears as both an asset and an identical liability, so it inflates the balance sheet without belonging to shareholders. Stripping it out, total assets were $36,565.9 million at June 30, 2026, down 5.7% from $38,768.1 million at December 31, 2025.

Unlimited U.S.-market analysis, $9.99/month

CME Group (CME) Q2 2026: Trading Fees Slip 2.6%, Market Data Hits Record $238M

This article became available on August 20, 2026. Subscribe to read in full, or wait until November 18, 2026 when it becomes free.

Cancel anytime. Full refund within 7 days.

Access is tied to your account. Subscribe with the same email you sign up with — if you already paid, sign up with that email and it unlocks automatically.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free daily briefing

The U.S. market, every morning — free

LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.

Get LineVest Daily — free →
This company

Full report on CME Group

We read CME Group's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the CME Group report
Every name you watch

Follow the whole market

Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.

$9.99 · monthly

Subscribe

Independent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.